EIT Health Flagship Call 2024

EIT Health Flagship Call 2024

Type of grant: Cascade funding

Opening date: 15 January 2024

Deadline model: multiple cut-off

Deadline dates:
28 February 2024 17:00 (Brussels time)

Status: Open for submission

Expected duration of participation: 1 - 3 years

Total funding available: €11.00

Project acronym: HORIZONEIT2022HEALTH

Full name of the EU funded project: EIT Health Business Plan 2023-2025

Grant agreement number: 101112921

Topic: HORIZON-EIT-2023-25-KIC-EITHEALTH - EIT Health Business Plan 2023-2025

Submission & evaluation process

The Flagships Call will consist of a one-year long call with two application deadlines, known as

cut-off dates: 28 February 2024 and 18 September 2024.

• The cut-off dates are the deadlines for short proposals and/or single proposal submission.

• It is important to note that not all activities called within the Flagship framework will be

called at both cut-offs.

The application will be done through the EIT Health Application Platform.

New applicants will need to register on the application platform available here. https://eithealth-apply.eu-1.smartsimple.eu/s_Login.jsp

Selection process

The selection process aims to ensure that applicants provide information for evaluation only at the necessary moment in the selection funnel, while strengthening proposals to maximise the success and impact of activities ultimately welcomed into the EIT Health portfolio. A quality threshold of minimum 70% of the maximum obtainable points applies at the relevant selection steps. The selection process will vary according to the single stage or two-stage submission evaluation.

Single stage submission

For single stage submissions the selection process is planned to last one month. Please consider that for the single stage evaluation process the number of steps is reduced

Two-stage submission

For two-stage (Short + Full proposal) submissions, the selection process is expected to last up to 4.5 months from the short proposal submission to the final selection notification.

Filtering

Consortiums will be invited to submit a short or single proposal form (accessible through EIT Health’s application platform), as applicable, as well as general information on their activity. For single stage submissions, all details are expected at the submission date.

In the two-stage submission process, the activity plan may not be fully finalised, and the

consortiums may not be complete at the short proposal stage.

The minimum requirements for applying (including eligibility criteria) are specified in the call document (see Further information below).

In addition to eligibility checking, EIT Health will perform a high-level assessment of general alignment of the proposal with the Flagships call based on strategic fit, potential future impact,and activity feasibility. This will yield a yes/no decision on the progression of the proposals in the evaluation process.

Pre-selection

Pre-selection is only applicable to the two-stage evaluation approach.

Proposals that pass the filtering step will go through a pre-selection evaluation consisting of an online pitch in front of external evaluators.

Support programme

The support programme is only applicable to the two-stage evaluation approach.

The support programme provides an opportunity for each invited consortium to work furtheron their activity plan, complete their team, and strengthen their ideas through mentoring and coaching.

Due diligence

All micro and small enterprises acting as commercialising entities and applying to Technology or Service Development activities or DiGinnovation programme must go through a due diligence process to assess the company potential.

Final selection

The final selection phase will be facilitated for all consortiums who submit complete full

proposals and complete single stage proposals.This phase will consist of an external evaluation and an Ethical, Legal and Social Issues (ELSI)

review. The external evaluation will take the form of a remote review for all calls, except for Technology and Service Development activities, for which the external evaluation will involve Hearings.

Further information

Please see the full call document here: https://eithealth.eu/wp-content/uploads/2024/01/EIT-Health-Flagships-2024_-Call-Document.pdf

Task description

With the ambition to contribute to some of the top health priorities that have been identified at EU level, EIT Health is calling for activities in Innovation and Transformation through funding different activities/programmes in each Flagship.

New models to deliver healthcare (NMDH)

The selected activities will deliver innovative solutions that provide compelling evidence, based on patient reported outcomes and real-world data, which can convince payors that the value brought to the patient justifies the evolution of the reimbursement models, thereby promoting the incorporation of innovative solutions and services into new markets. EIT Health welcome consortiums including healthcare service providers and their corresponding payors, steered by industry providers that have reached commercialisation stage to apply to Service Development activities.

Several transversal activities will support innovators and change agents along their entire

innovation journey. The online EIT Health Academy and, more specifically, the High Value Care track, will provide ongoing support and learning modules towards upskilling graduates and

professionals. To strengthen this track, EIT Health welcome consortiums who could deliver

Flagship-related content courses that will contribute to the EIT Labelled fellowship on advanced high value care principles.

Digital Transformation of Healthcare (DTH)

EIT Health welcome applications from consortiums who have reached Proof of Value or Initial Clinical Trials (IML 5-6) stage within the Technology Development activities. These activities aim to validate regulatory approvals of digital medical devices. It is strongly recommended, if applicable, that such activities leverage existing health registries or biobanks, to expedite the clinical validation of their solutions and market access.

Further start-ups and scale-ups with CE-marked, patient-centered DMDs (level IML7 - Validationof Solution and IML8 - Approval & Launch) are invited to apply to the DiGinnovation Programme, that is aimed at supporting the activity to achieve reimbursement coverage (IML9- Clinical Use).

Several transversal activities will support innovators and change agents along their entire

innovation and transformation journey. While Innovation Days (i-Days) kick-off the mindset to foster changes among the earliest entrepreneurs, who can also enhance their skills within a Master Degree programme, the online EIT Health Academy will provide ongoing support and learning modules upskilling Master and PhD level learners as well as healthcare and medical professionals in digital health topics through the Labelled Fellowship Programme. Further, non-degree education modules will be set-up and delivered through the EIT Health Academy that aim at raising awareness and attracting talents to the healthcare sector, in addition to training professionals in the technical competencies needed in a digitally transformed health system.